- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06617338
Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty
The goal of this clinical trial is to learn if preparing the target alignment of the operative side in total knee arthroplasty (TKA) based on the non-arthritic side will give the patient better overall alignment, function, and improved results compared to basing our implant alignment and positioning off the arthritic side, which is currently the traditional method.
The main questions it aims to answer are:
- Will a patient have improved postoperative TKA results if the implant alignment is based off the non-arthritic side compared to the standard arthritic side?
- What are the similarities or differences between study arms with respect to final implant alignment and positioning angles? Researchers will compare the outcomes of two cohorts of patients undergoing primary robotic-assisted total knee arthroplasty (RA-TKA) with normal contralateral knee. Based on preoperative CT imaging, the researchers will use normal contralateral side joint numbers as the target alignment for one group (Experimental arm) and utilize the traditional method for the other group (Active comparator arm). Clinical outcomes and patient-reported outcome measures (PROMs) will be compared between groups.
Participants will:
- Be randomized into one of two study arms and will receive either a unilateral knee CT or bilateral knee CT preoperatively
- Follow-up in the clinic at 2 weeks, 6 weeks and 1-year postoperatively, per standard-of-care for x-ray and clinical evaluation.
- Complete postop questionnaires (PROMs) at the prescribed follow-up intervals
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- UofL Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient age is 21-89 at time of surgery
- Patient is indicated to undergo a unilateral primary TKA, secondary to osteoarthritis
- Patient's contralateral knee is non-arthritic
- Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization document
- Patient is able to read and speak English.
Exclusion Criteria:
- Patient is under the age of 21
- Patient's primary diagnosis is not osteoarthritis
- Patient is unable to read and speak English
- History of previous DVT/PE
- History of stroke, CABG, or A fib
- Current smoker
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Participant receives bilateral knee CT preoperatively
The P.I. (Dr.
Malkani) will use normal contralateral side joint numbers as the target alignment for RA-TKA
|
Intervention given to the Experimental Arm
|
|
Active Comparator: Participant receives unilateral CT of the operative knee preoperatively
The P.I. will use the traditional method to obtain target alignment for RA-TKA.
|
Intervention given to the Active Comparator arm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Satisfaction
Time Frame: 1-year postoperatively
|
Overall Satisfaction with TKA using a Likert scale
|
1-year postoperatively
|
|
Pain VAS
Time Frame: preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
|
Level of knee pain (scale of zero to ten) using the Visual Analog Scale (VAS)
|
preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
|
|
KOOS JR
Time Frame: preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
|
KOOS JR questionnaire
|
preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
|
|
Forgotten Joint Score
Time Frame: preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
|
FJS-12 questionnaire
|
preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
|
|
PROMIS-10 Mental and Physical Health scores
Time Frame: preoperatively and 1-year postoperatively
|
PROMIS-10 Global Health questionnaire
|
preoperatively and 1-year postoperatively
|
|
Incidence of revision TKA
Time Frame: 1 year postop
|
postoperative complication requiring a revision total knee arthroplasty
|
1 year postop
|
|
non-revision complication
Time Frame: 1 year postop
|
postoperative complication requiring a non-revision procedure
|
1 year postop
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Active ROM
Time Frame: preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
|
Active knee range of motion: active extension, active flexion
|
preoperatively, 6 weeks (± 2 weeks), and 1-year postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24.0701
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.